Immunochemistry Diagnostic Devices And Equipment Market Research Reveals Path To $6.21 Billion By 2030

The immunochemistry diagnostic devices and equipment market is positioned for substantial growth, driven by technological advancements and increasing demand for precise diagnostic solutions. This sector is evolving rapidly as healthcare providers seek more efficient tools to detect and monitor various diseases, paving the way for innovations that improve patient outcomes and streamline laboratory workflows.

Forecasted Expansion in the Immunochemistry Diagnostic Devices and Equipment Market
The market for immunochemistry diagnostic devices and equipment is projected to experience significant expansion, reaching a value of $6.22 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 10.9% during the forecast period. Key factors contributing to this upward trajectory include greater demand for accurate diagnostic methods, the rising use of automated laboratory systems, the spread of personalized medicine, increasing investments in cutting-edge diagnostic technologies, and an intensified focus on early disease identification. Noteworthy trends shaping this market include the wider adoption of automated immunoassay analyzers, growing preference for highly sensitive diagnostic reagents, expanded utilization of multiplex testing platforms, enhanced laboratory automation solutions, and an emphasis on improving workflow efficiency and diagnostic accuracy.

Download a free sample of the immunochemistry diagnostic devices and equipment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2547&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Players Leading the Immunochemistry Diagnostic Devices and Equipment Market
Several influential companies dominate the immunochemistry diagnostic devices and equipment industry. These include Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, Diamond Diagnostics Inc., Dynex Technologies Inc., Grifols S.A., Hycor Biomedical LLC, Immunodiagnostic Systems, Inova Diagnostics, LabCorp, Mindray Medical International Limited, Ortho Clinical Diagnostics, Quest Diagnostics, Randox Laboratories, Sysmex Corporation, ThermoFisher Scientific Inc., Tosoh Bioscience, Danaher Corporation, Johnson & Johnson, Boditech Med Inc., Beckman Coulter Inc., Bio-Rad Laboratories, bioMérieux Clinical Diagnostics, Carolina Liquid Chemistries Corporate, DiaSorin Inc., Agilent Technologies Inc., Merck KGAA, Eagle Biosciences Inc., Biocare Medical LLC, Elabscience Biotechnology Inc., Bio-Genex Laboratories Inc., Diagnostic Biosystem, Histo-Line Laboratories, Rockland Immunochemicals Inc., Abcam plc, Becton dic*kinson & Company, Cell Signaling Technology Inc., ImmunoChemistry Technologies LLC, Genemed Biotechnologies Inc., Miltenyi Biotec GmbH, PerkinElmer Inc., Takara Bio Inc., Immucor Inc., and Quidel Corporation.

A Recent Strategic Acquisition in the Market
In January 2025, bioMérieux, a France-based in vitro diagnostics company, acquired SpinChip Diagnostics ASA for about $159.87 million. This acquisition aims to enhance bioMérieux's point-of-care diagnostic capabilities by incorporating SpinChip's rapid and highly sensitive immunoassay platform, which can produce results from a whole blood sample in roughly 10 minutes. SpinChip Diagnostics ASA, headquartered in Norway, is known for its expertise in developing point-of-care immunoassays for cardiac biomarkers, positioning bioMérieux to better serve this growing segment.

View the full immunochemistry diagnostic devices and equipment market report:
https://www.thebusinessresearchcompany.com/report/immunochemistry-diagnostic-devices-and-equipment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Shaping the Immunochemistry Diagnostic Devices and Equipment Market
To remain competitive, leading companies are focusing on developing new products such as multiplex assays. These assays allow for the simultaneous analysis of multiple analytes within a single biological sample, providing a comprehensive and efficient way to study various biomarkers at once.
For example, in June 2023, US-based biotechnology firm Navigate BioPharma Services, Inc. introduced advanced multiplex digital PCR assays designed for precise quantification of chimeric antigen receptor (CAR) T cells, a pioneering cancer immunotherapy. These assays utilize the Qiagen QIAcuity digital PCR System to measure CAR-T cell count, function, and persistence in clinical samples without requiring standard curves, detecting CAR-T cells at levels as low as 0.01%. This innovation supports clinicians in monitoring patient responses and safety during clinical trials, encouraging the progress of CAR-T therapies through its high sensitivity, specificity, and operational efficiency.

Detailed Segmentation of the Immunochemistry Diagnostic Devices and Equipment Market
The market is categorized across several dimensions:
1) By Product Type: Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, and Consumables.
2) By Consumables: Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, and other Consumables.
3) By Application: Endocrinology, Oncology, Cardiology, Therapeutic Drug Development and Monitoring, Infectious Disease Testing, Drugs of Abuse Testing, and other areas.
4) By End User: Hospitals and Clinics, Diagnostic Laboratories, Research Labs and Institutes, Biopharmaceutical and Biotechnology Companies, among others.

Finer subcategories include:
- Immunochemistry Analyzers such as Chemiluminescence Immunoassay (CLIA) Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Radioimmunoassay (RIA) Analyzers, and Fluorescence Immunoassay (FIA) Analyzers.
- Immunochemistry Stainers divided into Automated and Manual types.
- Incubators including CO2 Incubators, Shaking Incubators, and Heated Incubators.
- Microscopes categorized as Light, Fluorescence, and Electron Microscopes.
- Centrifuges such as Microcentrifuges, Refrigerated Centrifuges, and Ultracentrifuges.
- Autoclaves including Tabletop, Vertical, and Horizontal types.
- Consumables covering reagents and kits, test plates, filters and membranes, microplates, and accessories.

This comprehensive segmentation highlights the diverse and evolving nature of the immunochemistry diagnostic devices and equipment market, providing insights into the multiple facets of this expanding industry.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.